Earnings Call Insights: Cognex Corporation (CGNX) Q4 2025 Management View Matt Moschner, President, CEO & Director, opened by noting "2025 marked a return to profitable growth for Cognex, with constant currency revenue growth of 8% year-over-year and adjusted EPS growth of 38%." He highlighted momentum in logistics and factory automation, and emphasized progress on three strategic objectives: lead...
Earnings Call Insights: Cognex Corporation (CGNX) Q4 2025 Management View Matt Moschner, President, CEO & Director, opened by noting "2025 marked a return to profitable growth for Cognex, with constant currency revenue growth of 8% year-over-year and adjusted EPS growth of 38%." He highlighted momentum in logistics and factory automation, and emphasized progress on three strategic objectives: leading in AI for industrial machine vision, delivering the best customer experience, and aiming to double the customer base within five years. Moschner described several AI-driven product launches, including DataMan 290, In-Sight 8900, OneVision, and SLX, stating these "strengthen our position within approximately $3.2 billion of our $7 billion served market" and support market share gains. Moschner announced the exit from product lines generating $22 million of no growth or low margin revenue and a planned $35 million to $40 million in annualized cost reductions by year-end 2026, saying, "We remain focused on increasing productivity in key areas...using new digital tools, software development, using AI-assisted code generation, and automating back-office processes." Dennis Fehr, Senior VP of Finance & CFO, stated, "We ended 2025 with an adjusted EBITDA margin of 20.7%, excluding the one-time benefit from the Commercial Partnership. We achieved our first milestone, reaching greater than 20% a full year ahead of plan, driven by focused execution and strong cost discipline." Fehr added, "We are raising our through-cycle adjusted EBITDA margin range to 25%, 31% from the prior 20%, 30%. Our through-cycle revenue CAGR remains 13%, 14%, and we continue to expect greater than 100% free cash flow conversion." Outlook Fehr guided Q1 2026 revenue between $235 million and $255 million, "representing growth of approximately 13% at the midpoint against a weak comp." Adjusted EBITDA margin is expected between 19% and 22%, with the midpoint "representing an increase of 370 basis points year-...
Earnings Call Insights: Agios Pharmaceuticals (AGIO) Q4 2025 Management View CEO Brian Goff emphasized the company's 2026 strategic priorities, stating, "we're focused on executing a high-impact launch of AQVESME for the treatment of thalassemia in the U.S." He highlighted plans to expand the PK activation franchise into new indications, including sickle cell disease and lower-risk myelodysplastic...
Earnings Call Insights: Agios Pharmaceuticals (AGIO) Q4 2025 Management View CEO Brian Goff emphasized the company's 2026 strategic priorities, stating, "we're focused on executing a high-impact launch of AQVESME for the treatment of thalassemia in the U.S." He highlighted plans to expand the PK activation franchise into new indications, including sickle cell disease and lower-risk myelodysplastic syndrome, with key catalysts expected in 2026. Goff noted, "PYRUKYND delivered $20 million in net revenue in the fourth quarter, bringing full year 2025 revenue to $54 million, reflecting robust year-on-year growth." He reported FDA approval for AQVESME just before year-end and stated, "the U.S. thalassemia launch is underway." Goff pointed to a strong balance sheet: "We continue to operate from a position of strength, ending the year with approximately $1.2 billion in cash, providing flexibility to maximize the AQVESME thalassemia U.S. launch, pursue the path forward for mitapivat in sickle cell disease and continue to advance our pipeline programs." CFO Cecilia Jones stated, "Fourth quarter worldwide PYRUKYND revenue was $20 million, an increase of 86% compared to the fourth quarter of 2024 and a sequential increase of 55% compared to $13 million in the third quarter of 2025." Jones added, "In 2026, we expect U.S. PK deficiency revenues to be in the range of $45 million to $50 million." Chief Commercial Officer Tsveta Milanova described early AQVESME launch progress: "As of January 30, we have seen 44 prescriptions written by REMS-certified physicians in the U.S., which reflects strong early recognition of AQVESME clinical value and excellent execution by our field teams." Outlook U.S. PK deficiency revenues are projected in the range of $45 million to $50 million for 2026, according to CFO Jones. Operating expenses in 2026 are anticipated to be "roughly flat with 2025," reflecting investments in the AQVESME U.S. launch and gated investment for sickle cell disease. Manag...
Cash flow matters to Boeing (NYSE: BA) . Not only does Boeing need to fund a new narrowbody airplane within the next decade, but it also needs to pay down the debt built up during the lockdowns and 737 MAX groundings. However, its cash flow generation could be coming under pressure. President Trump's executive orders aimed at ensuring defense contractors deliver on time. Here's the lowdown. The co...
Cash flow matters to Boeing (NYSE: BA) . Not only does Boeing need to fund a new narrowbody airplane within the next decade, but it also needs to pay down the debt built up during the lockdowns and 737 MAX groundings. However, its cash flow generation could be coming under pressure. President Trump's executive orders aimed at ensuring defense contractors deliver on time. Here's the lowdown. The company's consolidated debt stood at $54.1 billion at the end of 2025, while its cash and marketable securities totaled $29.4 billion, resulting in $24.7 billion in net debt. It also burned through $1.9 billion in cash in 2025. Meanwhile, the former CEO, Dave Calhoun, is on record as saying a new narrowbody would cost $50 billion to develop. In addition, Boeing needs to support the recently acquired Spirit AeroSystems, its electric vertical takeoff and landing (eVTOL) business , Wisk, the ramp-up of 737 deliveries, the inventory build for the delayed 777X program, and customer considerations related to the 777X delay. Continue reading
Despite some outstanding reports from the big hyperscalers last week, including Alphabet , Microsoft , and Amazon , the market sent their stock prices down on worries about overspending on artificial intelligence (AI). Data by YCharts. Continue reading
Despite some outstanding reports from the big hyperscalers last week, including Alphabet , Microsoft , and Amazon , the market sent their stock prices down on worries about overspending on artificial intelligence (AI). Data by YCharts. Continue reading
Tim Cook, chief executive officer of Apple Inc., during the 60th presidential inauguration in the rotunda of the US Capitol in Washington, DC, US, on Monday, Jan. 20, 2025. Bloomberg | Getty Images Apple is having its worst day in the stock market in months. Shares of Apple were down 5% Thursday as reports surfaced about delays with Siri and its news app faced Federal Trade Commission scrutiny ove...
Tim Cook, chief executive officer of Apple Inc., during the 60th presidential inauguration in the rotunda of the US Capitol in Washington, DC, US, on Monday, Jan. 20, 2025. Bloomberg | Getty Images Apple is having its worst day in the stock market in months. Shares of Apple were down 5% Thursday as reports surfaced about delays with Siri and its news app faced Federal Trade Commission scrutiny over political bias . The long-awaited artificial intelligence update to the iPhone-maker's personal assistant Siri has been internally pushed back to May and potentially later, Bloomberg reported Wednesday. The update was expected to launch within a couple weeks, but the company may roll the features out slowly over several months, the report stated. Apple told CNBC it is still on track to launch in 2026. On Wednesday, the FTC Chair Andrew Ferguson told Apple CEO Tim Cook to review the terms of service and curation policies on Apple News. Ferguson cited recent "reports" that Apple News was promoting left-leaning news outlets while suppressing conservative content. Last month, Apple beat Wall Street expectations when it reported first-quarter earnings, however, the stock has been tied to Wall Street's recent concerns about big tech spending too much on AI. CNBC's Steve Kovach contributed to this report. Read more CNBC tech news Tech IPO hype gets drowned out on Wall Street by prospect of $1 trillion in debt sales FTC tells Tim Cook to look into reports Apple News is censoring conservatives Anthropic closes $30 billion funding round as cash keeps flowing into top AI startups Waymo begins deploying next-gen Ojai robotaxis to extend its U.S. lead
Banco Latinoamericano press release ( BLX ): Q4 GAAP EPS of $1.50. Revenue of $88.8M (+13.3% Y/Y). Net Interest Income ("NII") improved to $70.8 million in 4Q25 (+6% YoY) and $271.2 million in FY25 (+5% YoY), mostly driven by higher average business volumes. More on Banco Latinoamericano Bladex: Practically Perfect Execution On Long-Term Plan Seeking Alpha’s Quant Rating on Banco Latinoamericano H...
Banco Latinoamericano press release ( BLX ): Q4 GAAP EPS of $1.50. Revenue of $88.8M (+13.3% Y/Y). Net Interest Income ("NII") improved to $70.8 million in 4Q25 (+6% YoY) and $271.2 million in FY25 (+5% YoY), mostly driven by higher average business volumes. More on Banco Latinoamericano Bladex: Practically Perfect Execution On Long-Term Plan Seeking Alpha’s Quant Rating on Banco Latinoamericano Historical earnings data for Banco Latinoamericano Dividend scorecard for Banco Latinoamericano Financial information for Banco Latinoamericano
Morsa Images/DigitalVision via Getty Images To be honest with you, I am not a huge fan of the home furnishings market. It is intensely competitive, and margins have a tendency to be slim. In the past, I have been neutral or negative on many companies that operate in this space. One such example can be seen by looking at Arhaus, Inc. ( ARHS ), a business that operates specifically as a provider of ...
Morsa Images/DigitalVision via Getty Images To be honest with you, I am not a huge fan of the home furnishings market. It is intensely competitive, and margins have a tendency to be slim. In the past, I have been neutral or negative on many companies that operate in this space. One such example can be seen by looking at Arhaus, Inc. ( ARHS ), a business that operates specifically as a provider of home furnishings. Its vertical business model empowers it to design and produce furniture, outdoor products, lighting products, textiles, and decor. It is a huge industry, worth around $100 billion annually if we focus on the U nited States alone. But in my previous article about the business, published in September of last year, I said that I needed more clarity on revenue and profits before being anything other than "N eutral." In addition to uncertainty associated with the economy and tariffs, I decided to reaffirm the business as a "Hold" candidate. Since then, the stock has pulled back some, dropping 4.5%, while the S&P 500 is up 3%. Even with that decline, however, the stock is up 68.7% since I first rated it a "Hold" back in March 2022. That is a bit above the 59.5% increase that the market has experienced. Looking at the data today, I see that the trading multiples of the company have come down. Management expects continued growth for 2025 in its entirety. And even though economic concerns remain problematic, especially since I believe that the U nited States is heading toward a recession, the stock is now priced at levels that I think make a bit of sense. Because of this, I believe that upgrading the company to a soft "Buy" is the right move. But this could change as new data comes in. Soon, that will be the case. In fact, on Feb. 26, management is expected to announce financial results for the final quarter of the company's 2025 fiscal year. Although revenue is expected to increase, earnings per share should contract some. But assuming that this is more of a blip ...
Manchester United secured an important 3-0 lead in the first leg of their Women’s Champions League playoff against Atlético Madrid. Goals from Elisabeth Terland and Melvine Malard bookended the first half before Julia Zigiotti Olme added a third late on as Marc Skinner’s side produced a professional performance away from home. These two were familiar opponents having met in Madrid back in October ...
Manchester United secured an important 3-0 lead in the first leg of their Women’s Champions League playoff against Atlético Madrid. Goals from Elisabeth Terland and Melvine Malard bookended the first half before Julia Zigiotti Olme added a third late on as Marc Skinner’s side produced a professional performance away from home. These two were familiar opponents having met in Madrid back in October in the league phase. United came out with a 1-0 win on that occasion in an eventful encounter in which both sides were reduced to 10 players. Continue reading...
Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha More on DraftKings DraftKings Q4 Earnings Preview: Buybacks Over Deleveraging Are Prediction Markets Really A Threat To DraftKings? DraftKings: The Market Should (And Will) Have Some Faith DraftKings slides after softer-than-expected revenue guidance DraftKings Non-GAAP EPS of $0.36 misses by $0.05, revenue of $1.9...
Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha More on DraftKings DraftKings Q4 Earnings Preview: Buybacks Over Deleveraging Are Prediction Markets Really A Threat To DraftKings? DraftKings: The Market Should (And Will) Have Some Faith DraftKings slides after softer-than-expected revenue guidance DraftKings Non-GAAP EPS of $0.36 misses by $0.05, revenue of $1.99B in-line
Nancy Guthrie is among the thousands of people who go missing in the U.S. each year. But experts describe her case as "strange," with many unique details, from her age to her celebrity daughter.
Nancy Guthrie is among the thousands of people who go missing in the U.S. each year. But experts describe her case as "strange," with many unique details, from her age to her celebrity daughter.
In January, James Zimmerman returned to the American Chamber of Commerce in China (AmCham China) as its chairman. He previously served in that role for four one-year terms in 2007, 2008, 2015 and 2016. A lawyer by training and a resident of China for 28 years, Zimmerman has witnessed the rise of the world’s second-largest economy, the challenges it has faced and the attendant changes to how Americ...
In January, James Zimmerman returned to the American Chamber of Commerce in China (AmCham China) as its chairman. He previously served in that role for four one-year terms in 2007, 2008, 2015 and 2016. A lawyer by training and a resident of China for 28 years, Zimmerman has witnessed the rise of the world’s second-largest economy, the challenges it has faced and the attendant changes to how American businesses operate in the country. In this interview, Zimmerman assesses the potential of US...
watch now In this video AMRQ-V Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email CNBC Explains Why Greenland’s critical minerals won’t make it rich In early 2026, Greenland found itself in the middle of a geopolitical battle. Strategically positioned near emerging shipping routes, the island has drawn interest from the U.S., Russia, China...
watch now In this video AMRQ-V Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email CNBC Explains Why Greenland’s critical minerals won’t make it rich In early 2026, Greenland found itself in the middle of a geopolitical battle. Strategically positioned near emerging shipping routes, the island has drawn interest from the U.S., Russia, China and Europe. But Greenland’s untapped wealth sits under the ground. With significant deposits of rare earth elements and other critical minerals, the mining industry could boost the territory’s slowing economy. But can it make its people rich? 14:10 4 hours ago Gaelle Legrand